The purpose of this task order is the development and delivery of a quality assurance/quality control (QA/QC) plan and participation in the task order initiation meeting.
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76 Part of University Of Texas System
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,967
Award facts
- Opportunity
-
- 75N93021F00002 Solicitation number
- Contract value 100% obligated
- $2,967.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Galveston, TX 77555, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$70 | |
| Original award | $3,037 |
About this award
The University of Texas Medical Branch at Galveston was awarded a $2,967 delivery order against the Preclinical Services for HIV Therapeutics master IDIQ contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The purpose of this task order is for UTMB to develop and deliver a quality assurance/quality control plan and participate in a task order initiation meeting to support preclinical services for HIV therapeutics. Work will be performed in Galveston, Texas from April to August 2021 on a cost-no-fee basis. No subcontractors or set aside designations were identified. This task order provides specialized technical and administrative support to NIH's ongoing research efforts aimed at developing treatments and prevention methods for HIV/AIDS.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $2,967 on 75N93021F00002.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under 75N93021D00011, an indefinite delivery contract, on Preclinical Services for HIV Therapeutics.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award